Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

By News Health
1 month Ago

(MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…

Source link : https://www.medpagetoday.com/dermatology/psoriasis/116153

Author :

Publish date : 2025-06-18 20:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Was Trump Diagnosed With?

Suicidality in Older Adults; Opioid Use Disorder Treatment in Primary Care

Doctors in Elected Office Are Turning Their Backs on Science

When Systemic Therapy Is Delayed for Syphilitic Uveitis, Ceftazidime May Help

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Premature babies in UK to be immunised against winter virus RSV